全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Diagnostic and Therapeutic Value of ERCP in Acute Cholangitis

DOI: 10.1155/2013/191729

Full-Text   Cite this paper   Add to My Lib

Abstract:

Cholangitis, with a clinical spectrum between acute ascending cholangitis and acute fulminant cholangitis, the mildest and the most severe forms, respectively, is the infection of bile ducts with a potential of serious mortality and morbidity. Obstruction of the bile ducts followed by infection, with E. coli being the most commonly isolated agent, is common to all forms of cholangitis. Biliary obstruction is caused by choledocholithiasis mostly. “Choledochal pressure” is the most important factor, determining morbidity. If the pressure exceeds 25?cm H2O, which is the critical value, immune dysfunction ensues. Sepsis is common if the infection of biliary ducts is suppurative. Mortality and morbidity are inevitable if left untreated or drained late. The objective of this study is, in the stand point of the current literature, to analyse the diagnostic, therapeutic success and complication rates of ERCP (Endoscopic retrograde cholangiopancreatography) in patients with a diagnosis of acute purulent cholangitis with no response to medical treatment. 1. Introduction Inflammation of the biliary ducts is called cholangitis. Inflammatory process usually begins extrahepatically and easily spreads intrahepatically, causing bacteriemia. Cholangitis was first defined by Charcot in 1877. Obstruction of the biliary ducts and presence of a superposing bacterial infection are common features in cholangitis. The mildest clinical form is ascending cholangitis, and the most severe form is acute fulminant cholangitis. Not every biliary obstruction is associated with cholangitis but there is surely a biliary obstruction in every cholangitis case [1–4]. “Reynolds pentad” was defined with the addition of mental confusion and septic shock, in 1959, by Reynolds and Dragon, to the clinical findings known as “Charcot triad” (fever, abdominal pain, and jaundice) [5, 6]. Biliary obstruction is caused by choledocholithiasis mostly. Moreover, malignancy, benign strictures, and interventions to the biliary ducts may be the cause of biliary obstruction. Bacterial contamination of the biliary ducts may be caused by ascending infection or portal bacteriemia. That means cholangitis clinically. “Choledochal pressure” is the most important factor, determining morbidity. If the pressure exceeds 25?cm H2O, which is the critical value, hepatic defence mechanisms against infection are disrupted and immune dysfunction ensues. Obstruction of the biliary ducts, increased intraluminal pressure, and infected bile are important in the pathogenesis of cholangitis. In 25–40% of the cases, associated

References

[1]  B. M. Reynolds and E. L. Dargan, “Acute obstructive cholangitis; a distinct clinical syndrome,” Annals of Surgery, vol. 150, no. 2, pp. 299–303, 1959.
[2]  J. Y. Sung, J. W. Costerton, and E. A. Shaffer, “Defense system in the biliary tract against bacterial infection,” Digestive Diseases and Sciences, vol. 37, no. 5, pp. 689–696, 1992.
[3]  D. J. Andrew and S. E. Johnson, “Acute suppurative cholangitis, a medical and surgical emergency. A review of ten years experience emphasizing early recognition,” American Journal of Gastroenterology, vol. 54, no. 2, pp. 141–154, 1970.
[4]  H. Shimada, G. Nakagawara, and M. Kobayashi, “Pathogenesis and clinical features of acute cholangitis accompanied by shock,” Japanese Journal of Surgery, vol. 14, no. 4, pp. 269–277, 1984.
[5]  K. J. van Erpecum, “Complications of bile-duct stones: acute cholangitis and pancreatitis,” Best Practice and Research: Clinical Gastroenterology, vol. 20, no. 6, pp. 1139–1152, 2006.
[6]  T. P. Kinney, “Management of ascending cholangitis,” Gastrointestinal Endoscopy Clinics of North America, vol. 17, no. 2, pp. 289–306, 2007.
[7]  J. W. C. Leung, T. K. W. Ling, R. C. Y. Chan et al., “Antibiotics, biliary sepsis, and bile duct stones,” Gastrointestinal Endoscopy, vol. 40, no. 6, pp. 716–721, 1994.
[8]  K. Wada, T. Takada, Y. Kawarada et al., “Diagnostic criteria and severity assessment of acute cholangitis: Tokyo Guidelines,” Journal of Hepato-Biliary-Pancreatic Surgery, vol. 14, no. 1, pp. 52–58, 2007.
[9]  M. N. Sinanan, “Acute cholangitis,” Infectious Disease Clinics of North America, vol. 6, no. 3, pp. 571–599, 1992.
[10]  B. Jabara, K. M. Fargen, S. Beech, and D. R. Slakey, “Diagnosis of cholangiocarcinoma: a case series and literature review,” The Journal of the Louisiana State Medical Society, vol. 161, no. 2, pp. 89–94, 2009.
[11]  S. Attasaranya, E. L. Fogel, and G. A. Lehman, “Choledocholithiasis, ascending cholangitis, and gallstone pancreatitis,” Medical Clinics of North America, vol. 92, no. 4, pp. 925–960, 2008.
[12]  I. F. Yusoff, J. S. Barkun, and A. N. Barkun, “Diagnosis and management of cholecystitis and cholangitis,” Gastroenterology Clinics of North America, vol. 32, no. 4, pp. 1145–1168, 2003.
[13]  P. A. Lipsett and H. A. Pitt, “Acute cholangitis,” Surgical Clinics of North America, vol. 70, no. 6, pp. 1297–1312, 1990.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133